Hunan Fangsheng Pharmaceutical Future Growth
Future criteria checks 4/6
Hunan Fangsheng Pharmaceutical is forecast to grow earnings and revenue by 24.6% and 18.2% per annum respectively. EPS is expected to grow by 24.3% per annum. Return on equity is forecast to be 15.6% in 3 years.
Key information
24.6%
Earnings growth rate
24.3%
EPS growth rate
Pharmaceuticals earnings growth | 18.6% |
Revenue growth rate | 18.2% |
Future return on equity | 15.6% |
Analyst coverage | Low |
Last updated | 11 Feb 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 2,507 | 284 | N/A | 457 | 2 |
12/31/2024 | 2,103 | 225 | N/A | 363 | 2 |
12/31/2023 | 1,802 | 173 | N/A | 339 | 2 |
9/30/2023 | 1,649 | 168 | -67 | 163 | N/A |
6/30/2023 | 1,774 | 329 | -25 | 171 | N/A |
3/31/2023 | 1,806 | 315 | 12 | 198 | N/A |
12/31/2022 | 1,792 | 286 | 130 | 302 | N/A |
9/30/2022 | 1,812 | 267 | 88 | 279 | N/A |
6/30/2022 | 1,710 | 91 | 48 | 244 | N/A |
3/31/2022 | 1,653 | 81 | 31 | 218 | N/A |
12/31/2021 | 1,567 | 70 | 1 | 186 | N/A |
9/30/2021 | 1,466 | 66 | -55 | 125 | N/A |
6/30/2021 | 1,425 | 68 | -2 | 191 | N/A |
3/31/2021 | 1,351 | 68 | 57 | 235 | N/A |
12/31/2020 | 1,279 | 64 | 69 | 237 | N/A |
9/30/2020 | 1,199 | 69 | 45 | 196 | N/A |
6/30/2020 | 1,134 | 63 | -10 | 128 | N/A |
3/31/2020 | 1,119 | 75 | -28 | 149 | N/A |
12/31/2019 | 1,094 | 79 | -37 | 163 | N/A |
9/30/2019 | 1,073 | 83 | -29 | 150 | N/A |
6/30/2019 | 1,078 | 81 | 45 | 195 | N/A |
3/31/2019 | 1,041 | 74 | 55 | 154 | N/A |
12/31/2018 | 1,051 | 73 | 101 | 176 | N/A |
9/30/2018 | 1,000 | 45 | 134 | 187 | N/A |
6/30/2018 | 919 | 60 | 17 | 116 | N/A |
3/31/2018 | 837 | 65 | -46 | 65 | N/A |
12/31/2017 | 721 | 60 | -116 | 17 | N/A |
9/30/2017 | 706 | 88 | -116 | 46 | N/A |
6/30/2017 | 634 | 78 | N/A | 79 | N/A |
3/31/2017 | 567 | 72 | N/A | 111 | N/A |
12/31/2016 | 534 | 70 | N/A | 119 | N/A |
9/30/2016 | 470 | 75 | N/A | 86 | N/A |
6/30/2016 | 457 | 81 | N/A | 76 | N/A |
3/31/2016 | 464 | 86 | N/A | 87 | N/A |
12/31/2015 | 469 | 91 | N/A | 91 | N/A |
9/30/2015 | 460 | 91 | N/A | 85 | N/A |
6/30/2015 | 445 | 86 | N/A | 99 | N/A |
3/31/2015 | 446 | 89 | N/A | 129 | N/A |
12/31/2014 | 416 | 81 | N/A | 94 | N/A |
9/30/2014 | 416 | 84 | N/A | 110 | N/A |
12/31/2013 | 400 | 73 | N/A | 123 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603998's forecast earnings growth (24.6% per year) is above the savings rate (2.9%).
Earnings vs Market: 603998's earnings (24.6% per year) are forecast to grow faster than the CN market (24.4% per year).
High Growth Earnings: 603998's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 603998's revenue (18.2% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 603998's revenue (18.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 603998's Return on Equity is forecast to be low in 3 years time (15.6%).